Specific activation of CMV-primed human T lymphocytes by cytomegalovirus pp65 expressed in fission yeast

被引:18
作者
Breinig, F
Heintel, T
Schumacher, A
Meyerhans, A
Schmitt, MJ
机构
[1] Univ Saarland, Angew Mol Biol, D-66041 Saarbrucken, Germany
[2] Univ Saarland, Abt Virol, Med Mikrobiol & Hyg, D-66421 Homburg, Germany
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2003年 / 38卷 / 03期
关键词
fission yeast; whole blood assay; HCMV pp65; yeast-based vaccine; T cell immune response;
D O I
10.1016/S0928-8244(03)00148-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Threatening virus infections constantly illustrate the growing need for novel vaccines that specifically induce efficient T cell-mediated immune responses. In this study, we used a human whole blood assay to determine the activation of antigen-specific human T lymphocytes by a viral antigen of human cytomegalovirus (HCMV). The major HCMV tegument protein pp65, recombinantly expressed in fission yeast (Schizosaccharomyces pombe), specifically activated antigen-specific CD4- and CD8-positive memory T cells in blood of HCMV seropositive donors. Moreover, the immune response against recombinant pp65, in particular that of CD8 class I major histocompatibility complex-restricted cytotoxic T cells, was similar to the response against the intact HCMV. Since fission yeast cells per se did not activate a significant number of human T lymphocytes ex vivo, the system described here might represent a novel approach in vaccine development as well as in the identification of vaccine candidates directly from human whole blood. (C) 2003 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:231 / 239
页数:9
相关论文
共 42 条
[1]   Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells [J].
Boppana, SB ;
Britt, WJ .
VIROLOGY, 1996, 222 (01) :293-296
[2]  
Clemons KV, 2000, MED MYCOL, V38, P99, DOI 10.1080/mmy.38.s1.99.111
[3]   Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection [J].
Diamond, DJ ;
York, J ;
Sun, JY ;
Wright, CL ;
Forman, SJ .
BLOOD, 1997, 90 (05) :1751-1767
[4]  
Fischli A, 1996, YEAST, V12, P977, DOI 10.1002/(SICI)1097-0061(199608)12:10<977::AID-YEA996>3.0.CO
[5]  
2-S
[6]  
FORMAN SJ, 1985, J IMMUNOL, V134, P3391
[7]   HIGH-LEVEL EXPRESSION OF HUMAN LIPOCORTIN-I IN THE FISSION YEAST SCHIZOSACCHAROMYCES-POMBE USING A NOVEL EXPRESSION VECTOR [J].
GIGAHAMA, Y ;
TOHDA, H ;
OKADA, H ;
OWADA, MK ;
OKAYAMA, H ;
KUMAGAI, H .
BIO-TECHNOLOGY, 1994, 12 (04) :400-404
[8]   Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8+ T lymphocytes in healthy seropositive donors [J].
Gillespie, GMA ;
Wills, MR ;
Appay, V ;
O'Callaghan, C ;
Murphy, M ;
Smith, N ;
Sissons, P ;
Rowland-Jones, S ;
Bell, JI ;
Moss, PAH .
JOURNAL OF VIROLOGY, 2000, 74 (17) :8140-8150
[9]  
GOSSELIN EJ, 1993, J IMMUNOL, V151, P1482
[10]   Antigen presentation in extracellular matrix:: Interactions of T cells with dendritic cells are dynamic, short lived, and sequential [J].
Gunzer, M ;
Schäfer, A ;
Borgmann, S ;
Grabbe, S ;
Zänker, KS ;
Bröcker, EB ;
Kämpgen, E ;
Friedl, P .
IMMUNITY, 2000, 13 (03) :323-332